These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 22186838)
1. Regression of intracranial aneurysms by simultaneous inhibition of nuclear factor-κB and Ets with chimeric decoy oligodeoxynucleotide treatment. Aoki T; Kataoka H; Nishimura M; Ishibashi R; Morishita R; Miyamoto S Neurosurgery; 2012 Jun; 70(6):1534-43; discussion 1543. PubMed ID: 22186838 [TBL] [Abstract][Full Text] [Related]
2. Regression of abdominal aortic aneurysms by simultaneous inhibition of nuclear factor kappaB and ets in a rabbit model. Miyake T; Aoki M; Masaki H; Kawasaki T; Oishi M; Kataoka K; Ogihara T; Kaneda Y; Morishita R Circ Res; 2007 Nov; 101(11):1175-84. PubMed ID: 17885220 [TBL] [Abstract][Full Text] [Related]
3. Pitavastatin suppresses formation and progression of cerebral aneurysms through inhibition of the nuclear factor kappaB pathway. Aoki T; Kataoka H; Ishibashi R; Nakagami H; Nozaki K; Morishita R; Hashimoto N Neurosurgery; 2009 Feb; 64(2):357-65; discussion 365-6. PubMed ID: 19190463 [TBL] [Abstract][Full Text] [Related]
4. Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model. Miyake T; Aoki M; Nakashima H; Kawasaki T; Oishi M; Kataoka K; Tanemoto K; Ogihara T; Kaneda Y; Morishita R Gene Ther; 2006 Apr; 13(8):695-704. PubMed ID: 16397509 [TBL] [Abstract][Full Text] [Related]
5. Reduced collagen biosynthesis is the hallmark of cerebral aneurysm: contribution of interleukin-1beta and nuclear factor-kappaB. Aoki T; Kataoka H; Ishibashi R; Nozaki K; Morishita R; Hashimoto N Arterioscler Thromb Vasc Biol; 2009 Jul; 29(7):1080-6. PubMed ID: 19359664 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappaB and ets transcription factors. Nakashima H; Aoki M; Miyake T; Kawasaki T; Iwai M; Jo N; Oishi M; Kataoka K; Ohgi S; Ogihara T; Kaneda Y; Morishita R Circulation; 2004 Jan; 109(1):132-8. PubMed ID: 14662712 [TBL] [Abstract][Full Text] [Related]
7. [Transfection of nuclear factor-kappaB decoy oligodeoxynucleotides prevents ischemic acute renal failure in rats]. Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF Zhonghua Yi Xue Za Zhi; 2003 Sep; 83(18):1597-602. PubMed ID: 14642117 [TBL] [Abstract][Full Text] [Related]
8. NF-kappaB is a key mediator of cerebral aneurysm formation. Aoki T; Kataoka H; Shimamura M; Nakagami H; Wakayama K; Moriwaki T; Ishibashi R; Nozaki K; Morishita R; Hashimoto N Circulation; 2007 Dec; 116(24):2830-40. PubMed ID: 18025535 [TBL] [Abstract][Full Text] [Related]
9. Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model. Uemura T; Tsujii M; Akeda K; Iino T; Satonaka H; Hasegawa M; Sudo A J Gene Med; 2012 Nov; 14(11):623-31. PubMed ID: 23080520 [TBL] [Abstract][Full Text] [Related]
10. Systemic administration of ribbon-type decoy oligodeoxynucleotide against nuclear factor κB and ets prevents abdominal aortic aneurysm in rat model. Miyake T; Aoki M; Osako MK; Shimamura M; Nakagami H; Morishita R Mol Ther; 2011 Jan; 19(1):181-7. PubMed ID: 20877343 [TBL] [Abstract][Full Text] [Related]
11. Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy. Kim KH; Lee ES; Cha SH; Park JH; Park JS; Chang YC; Park KK Exp Mol Pathol; 2009 Apr; 86(2):114-20. PubMed ID: 19118545 [TBL] [Abstract][Full Text] [Related]
12. [Effect of nuclear factor-kappa B decoy oligodeoxynucleotides on IL-10, IL-13 and nuclear factor-kappa B protein expressions in rabbits with severe lung contusion]. Fang DQ; Yu T; Wan L Nan Fang Yi Ke Da Xue Xue Bao; 2010 Oct; 30(10):2284-7. PubMed ID: 20965826 [TBL] [Abstract][Full Text] [Related]
13. Effects of chimeric decoy oligodeoxynucleotide in the regulation of transcription factors NF-κB and Sp1 in an animal model of atherosclerosis. Lee WR; Kim KH; An HJ; Park YY; Kim KS; Lee CK; Min BK; Park KK Basic Clin Pharmacol Toxicol; 2013 Apr; 112(4):236-43. PubMed ID: 23107157 [TBL] [Abstract][Full Text] [Related]
14. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy. Tomita T; Takeuchi E; Tomita N; Morishita R; Kaneko M; Yamamoto K; Nakase T; Seki H; Kato K; Kaneda Y; Ochi T Arthritis Rheum; 1999 Dec; 42(12):2532-42. PubMed ID: 10615998 [TBL] [Abstract][Full Text] [Related]
15. [The inhibitory effects of dumb-bell decoy oligodeoxynucleotides targeting NF-kappaB on the growth of multiple myeloma cells and IL-6 expression]. Jiang HL; Xue WJ; Liu H; Chen W Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):47-50. PubMed ID: 16388744 [TBL] [Abstract][Full Text] [Related]
16. Cell death in NF-kappaB-dependent tumour cell lines as a result of NF-kappaB trapping by linker-modified hairpin decoy oligonucleotide. Laguillier C; Hbibi AT; Baran-Marszak F; Metelev V; Cao A; Cymbalista F; Bogdanov A; Fagard R FEBS Lett; 2007 Mar; 581(6):1143-50. PubMed ID: 17328896 [TBL] [Abstract][Full Text] [Related]
17. Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis. Matsuda N; Hattori Y; Jesmin S; Gando S Mol Pharmacol; 2005 Apr; 67(4):1018-25. PubMed ID: 15576632 [TBL] [Abstract][Full Text] [Related]
18. Suppression of nuclear factor-kappaB activity in Kupffer cells protects rat liver graft from ischemia-reperfusion injury. Li JD; Peng Y; Peng XY; Li QL; Li Q Transplant Proc; 2010 Jun; 42(5):1582-6. PubMed ID: 20620478 [TBL] [Abstract][Full Text] [Related]
19. Effect of NF-κB decoy oligodeoxynucleotide on LPS/high-fat diet-induced atherosclerosis in an animal model. Kim SJ; Park JH; Kim KH; Lee WR; Lee S; Kwon OC; Kim KS; Park KK Basic Clin Pharmacol Toxicol; 2010 Dec; 107(6):925-30. PubMed ID: 20649557 [TBL] [Abstract][Full Text] [Related]
20. Ets-1 promotes the progression of cerebral aneurysm by inducing the expression of MCP-1 in vascular smooth muscle cells. Aoki T; Kataoka H; Nishimura M; Ishibashi R; Morishita R; Miyamoto S Gene Ther; 2010 Sep; 17(9):1117-23. PubMed ID: 20428211 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]